Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelial dysfunction in HIV infection.

Bruno R Cotter1

  • 1University of California San Diego Medical Center, 200 West Arbor Street, San Diego, CA 92103-8411, USA. bcotter@ucsd.edu

Current HIV/AIDS Reports
|September 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Quantitation of Saline Bubble Studies in Patients with Liver Cirrhosis.

Ultrasound in medicine & biology·2023
Same author

Optimal Quantification of Functional Mitral Regurgitation: Comparison of Volumetric and Proximal Isovelocity Surface Area Methods to Predict Outcome.

Journal of the American Heart Association·2021
Same author

Clinical and Echocardiographic Predictors of Reduced Survival in Patient with Functional Mitral Regurgitation.

The American journal of cardiology·2021
Same author

HIV and cardiovascular disease: much ado about nothing?

European heart journal·2018
Same author

Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation.

AIDS research and human retroviruses·2013
Same author

Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.

Journal of clinical lipidology·2009
Same journal

IAS 2025: Why Can't I Breastfeed My Baby When Evidence and Lived Experience Say I Can? A Call for Policy Equity for Mothers Living with HIV.

Current HIV/AIDS reports·2026
Same journal

Cytomegalovirus and HIV Co-Infections During Pregnancy and Early Childhood.

Current HIV/AIDS reports·2026
Same journal

HIV Reservoirs in Brain parenchyma and Cerebrospinal Fluid During Suppressive ART: Same-Same or Very Different?

Current HIV/AIDS reports·2026
Same journal

HIV-1 Tat-driven Glutamate Dysregulation: Implications for Cognitive Impairment in HAND.

Current HIV/AIDS reports·2026
Same journal

Central Nervous System HIV Persistence and Clinical Consequences During Suppressive ART.

Current HIV/AIDS reports·2026
Same journal

Expanding PrEP Access Through Decentralized Delivery Models.

Current HIV/AIDS reports·2026
See all related articles

Highly active antiretroviral therapy (HAART) improves HIV prognosis but may increase cardiovascular risks. Endothelial dysfunction in HIV patients is complex, influenced by the virus, immune response, and HAART, necessitating further research.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Highly active antiretroviral therapy (HAART) has transformed HIV management, improving patient outcomes.
  • However, protease inhibitors within HAART regimens are linked to increased cardiovascular events.
  • Coronary heart disease risk factors like dyslipidemia, insulin resistance, and endothelial dysfunction are exacerbated.

Purpose of the Study:

  • To explore endothelial function in HIV-infected individuals.
  • To investigate the impact of HAART on endothelial dysfunction.
  • To understand the multifaceted causes of endothelial impairment in HIV.

Main Methods:

  • The study focuses on analyzing endothelial function in the context of HIV infection.
  • It examines how HAART, particularly protease inhibitors, influences endothelial health.

Related Experiment Videos

  • Research considers viral, immunological, and metabolic factors affecting endothelial function.

    • Main Results:

    • Endothelial dysfunction is a significant concern in HIV patients on HAART.
    • Both HIV infection and HAART contribute to endothelial dysfunction through various mechanisms.
    • Metabolic changes induced by HAART, affecting lipid and glucose metabolism, play a role.

    Conclusions:

    • Endothelial dysfunction is a critical factor in cardiovascular risk assessment for HIV patients.
    • Understanding the interplay between HIV, HAART, and endothelial function is crucial.
    • Further research is required to fully elucidate the significance of endothelial dysfunction in this population.